Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06935552
EARLY_PHASE1
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study
Official title: Ketamine and Lidocaine Infusion for Refractory Chronic Migraine: Comparative Study
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2025-06-01
Completion Date
2026-12
Last Updated
2025-04-20
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
Ketamine infusion
group A will receive ketamine intravenous infusion
DRUG
Lidocaine Intravenous Infusion
group B will receive lidocaine intravenous infusion
DRUG
Dextrose 5% in water
group C will only receive Dextrose 5% in water